Yiqun Chen1, Frank A Sloan2, Arseniy P Yashkin3. 1. Department of Economics, Duke University, 213 Social Sciences Building, Box 90097, Durham, NC, 27708. Electronic address: yiqun.chen@duke.edu. 2. Department of Economics, Duke University, 213 Social Sciences Building, Box 90097, Durham, NC, 27708. Electronic address: fsloan@duke.edu. 3. Department of Economics, Duke University, 213 Social Sciences Building, Box 90097, Durham, NC, 27708. Electronic address: arseniy.yashkin@duke.edu.
Abstract
AIMS: Analyze relationships between adherence to guidelines for diabetes care - regular screening; physical activity; and medication - and diabetes complications and mortality. METHODS: Outcomes were onset of congestive heart failure (CHF), stroke, renal failure, moderate complications of lower extremities, lower-limb amputation, proliferative diabetic retinopathy (PDR), and mortality during follow-up. Participants were persons aged 65+ in the Health and Retirement Study (HRS) 2003 Diabetes Study and had Medicare claims in follow-up period (2004-8). RESULTS: Adherence to screening recommendations decreased risks of developing CHF (odds ratio (OR)=0.83; 95% confidence interval (CI): 0.72-0.96), stroke (OR=0.80; 95% CI: 0.68-0.94); renal failure (OR=0. 82; 95% CI: 0.71-0.95); and death (OR=0.86; 95% CI: 0.74-0.99). Adherence to physical activity recommendation reduced risks of stroke (OR=0.64; 95% CI: 0.45-0.90), renal failure (OR=0.71; 95% CI: 0.52-0.97), moderate lower-extremity complications (OR=0.71; 95% CI: 0.51-0.99), having a lower limb amputation (OR=0.31, 95% CI: 0.11-0.85), and death (OR=0.56, 95% CI: 0.41-0.77). Medication adherence was associated with lower risks of PDR (OR=0.35, 95% CI: 0.13-0.93). CONCLUSIONS: Adherence to screening, physical activity and medication guidelines was associated with lower risks of diabetes complications and death. Relative importance of adherence differed among outcome measures.
AIMS: Analyze relationships between adherence to guidelines for diabetes care - regular screening; physical activity; and medication - and diabetes complications and mortality. METHODS: Outcomes were onset of congestive heart failure (CHF), stroke, renal failure, moderate complications of lower extremities, lower-limb amputation, proliferative diabetic retinopathy (PDR), and mortality during follow-up. Participants were persons aged 65+ in the Health and Retirement Study (HRS) 2003 Diabetes Study and had Medicare claims in follow-up period (2004-8). RESULTS: Adherence to screening recommendations decreased risks of developing CHF (odds ratio (OR)=0.83; 95% confidence interval (CI): 0.72-0.96), stroke (OR=0.80; 95% CI: 0.68-0.94); renal failure (OR=0. 82; 95% CI: 0.71-0.95); and death (OR=0.86; 95% CI: 0.74-0.99). Adherence to physical activity recommendation reduced risks of stroke (OR=0.64; 95% CI: 0.45-0.90), renal failure (OR=0.71; 95% CI: 0.52-0.97), moderate lower-extremity complications (OR=0.71; 95% CI: 0.51-0.99), having a lower limb amputation (OR=0.31, 95% CI: 0.11-0.85), and death (OR=0.56, 95% CI: 0.41-0.77). Medication adherence was associated with lower risks of PDR (OR=0.35, 95% CI: 0.13-0.93). CONCLUSIONS: Adherence to screening, physical activity and medication guidelines was associated with lower risks of diabetes complications and death. Relative importance of adherence differed among outcome measures.
Authors: Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden Journal: Ann Intern Med Date: 2004-09-21 Impact factor: 25.391
Authors: J I Blomster; C K Chow; S Zoungas; M Woodward; A Patel; N R Poulter; M Marre; S Harrap; J Chalmers; G S Hillis Journal: Diabetes Obes Metab Date: 2013-06-11 Impact factor: 6.577
Authors: Kimberley Krapek; Kathleen King; Susan S Warren; Karen G George; Dorothy A Caputo; Karen Mihelich; Elizabeth M Holst; Michael B Nichol; Sheng G Shi; Kevin B Livengood; Steve Walden; Teresa J Lubowski Journal: Ann Pharmacother Date: 2004-07-06 Impact factor: 3.154
Authors: Felicia J Bayer; Deron Galusha; Martin Slade; Isabella M Chu; Oyebode Taiwo; Mark R Cullen Journal: Am J Manag Care Date: 2014 Impact factor: 2.229
Authors: Yolanda V Martínez; Carlos A Prado-Aguilar; Ramón A Rascón-Pacheco; José J Valdivia-Martínez Journal: BMC Health Serv Res Date: 2008-07-30 Impact factor: 2.655
Authors: Igor Akushevich; Arseniy P Yashkin; Julia Kravchenko; Fang Fang; Konstantin Arbeev; Frank Sloan; Anatoliy I Yashin Journal: J Diabetes Complications Date: 2018-01-06 Impact factor: 2.852
Authors: Ludimila Forechi; José Geraldo Mill; Rosane Härter Griep; Itamar Santos; Francisco Pitanga; Maria Del Carmen Bisi Molina Journal: Rev Saude Publica Date: 2018-04-09 Impact factor: 2.106
Authors: Jacqueline M Bos; Stephanie Natsch; Patricia M L A van den Bemt; Johan L W Pot; J Elsbeth Nagtegaal; Andre Wieringa; Gert Jan van der Wilt; Peter A G M De Smet; Cornelis Kramers Journal: Int J Clin Pharm Date: 2017-11-03